Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
These data must be analyzed in an efficient and rapid manner to optimize formulations and processing parameters in order to expedite product development. The following analysis contains polymer testing data on a number of key attributes during both the R&D and Manufacturing cycles. Additionally, geographic and sample site information have been linked to the data in order to determine if there is any variability in the products produced that may be related to conditions outside of the manufacturing process. Formulations and process conditions have been coded for ease of understanding and to anonymize the data.
Your login attempt was not successful. Please try again.
Setup is fast and easy. Click below to register.
A Flash compatible player was not detected on your system, otherwise you would see videos here. If you can play an mp4, download the video as mp4 here